Pregabalin
Pregabalin is an anticonvulsant and neuropathic pain medicine used to treat nerve-related pain, fibromyalgia, and certain seizure disorders as adjunctive therapy. It is also prescribed for generalised anxiety disorder in some countries, depending on local regulatory approval. It works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters and helping control abnormal nerve signalling. It is available as oral capsules, tablets, and oral solutions. Common side effects include dizziness, drowsiness, blurred vision, dry mouth, and weight gain. Important risks include respiratory depression, swelling, allergic reactions, and dependence or withdrawal symptoms, particularly when combined with opioids or sedatives. Dosage should be adjusted in patients with kidney impairment, and treatment should not be stopped abruptly without medical guidance.
Pregabalin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Pregabalin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Pregabalin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Pregabalin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
